| Literature DB >> 30140155 |
Jun-Hao Shih1,2, Bing-Yan Zeng3, Pao-Yen Lin4,5, Tien-Yu Chen6,7, Yen-Wen Chen8, Ching-Kuan Wu9, Ping-Tao Tseng10, Ming-Kung Wu4.
Abstract
Evidence has suggested that dysregulation of the dopaminergic system may play a significant role in the pathogenesis of attention-deficit/hyperactivity disorder (ADHD) in children. Manganese, a neurotoxicant, has been reported to exert its neurotoxicity by affecting the dopaminergic system. However, the association between peripheral manganese levels and ADHD has not been comprehensively reviewed. This study aimed to investigate the association between peripheral manganese levels and ADHD in children. An electronic search was performed on databases including PubMed, ProQuest, ClinicalKey, Cochrane Library, ClinicalTrials.gov, Embase, Web of Science, and ScienceDirect with last search on March 25th, 2018. As per the inclusion criteria, human observational studies investigating peripheral manganese levels in children with ADHD and controls were included. The meta-analysis was performed using a random-effects model, and possible confounders were examined by subgroup analysis. In total, four articles with 175 ADHD children and 999 controls were recruited. The manganese levels were significantly higher in ADHD children than in controls (p=0.033), when studies investigating blood levels and those investigating hair levels were included. However, when only studies investigating blood levels were included, there was no significant difference between ADHD children and controls (p=0.076). Our results support higher peripheral manganese levels in children diagnosed with ADHD than those in controls. Further primary studies are needed to clarify this association.Entities:
Keywords: ADHD; manganese; meta-analysis; pediatric psychiatry; review
Year: 2018 PMID: 30140155 PMCID: PMC6054766 DOI: 10.2147/NDT.S165378
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1The flowchart of meta-analysis.
Abbreviation: ADHD, attention-deficit hyperactivity disorder.
Characteristics of the recruited studies
| Study | Criteria of ADHD | Sample source | Comparison | Subject | Mean age | Female (%) | Cognitive function
| ADHD subtype
| Parental history of ADHD | Country | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADHD (IQ) | Control (IQ) | Inattentive | Hyperactive | Combined | |||||||||
| Shin et al | DSM-IV | Hair | ADHD | 40 | 9.4±3.0 | 15.0 | 101.8±14.9 | 112.4±10.4 | N/A | N/A | N/A | Not mentioned | Republic of Korea |
| Control | 43 | 10.3±3.1 | 16.3 | ||||||||||
| Hong et al | DISC-IV | Blood | ADHD | 43 | 9.1±0.8 | 16.3 | 106.1±13.8 | 111.0±14.2 | N/A | N/A | N/A | Not mentioned | Republic of Korea |
| Control | 847 | 9.1±0.7 | 48.5 | ||||||||||
| Yousef et al | DSM-IV | Blood | ADHD | 18 | 8.3±1.8 | N/A | N/A | N/A | 38.9% | 33.3% | 27.8% | Not mentioned | United Arab Emirates |
| Control | 74 | ||||||||||||
| Farias et al | DSM-IV | Blood | ADHD-combined | 50 | 8.0±1.2 | 14.0 | 102.0±14.0 | 101.0±17.0 | 33.0% | 0.0% | 67.0% | Not mentioned | Brazil |
| ADHD-inattentive | 24 | 9.0±1.4 | 21.0 | 93.0±10.0 | |||||||||
| ADHD-combined and Mx | 21 | 9.0±1.8 | 19.0 | 98.0±14.0 | |||||||||
| ADHD-inattentive and Mx | 11 | 10.0±1.7 | 0.0 | 97.0±10.0 | |||||||||
| Control | 35 | 9.0±1.2 | 20.0 | ||||||||||
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; DISC-IV, Diagnostic Interview Schedule for Children Version IV; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; IQ, intelligence quotient; Mx, medication; N/A, not available.
Figure 2Meta-analysis of (A) overall manganese levels in ADHD children and controls, (B) blood manganese levels in ADHD children and controls, and (C) pooled adjusted OR for the association between manganese levels and ADHD.
Notes: (A) There were significantly higher overall manganese levels in ADHD children than those in controls (Hedges’ g=0.305, 95% CI=0.025–0.585, p=0.033). (B) There were no significantly different blood manganese levels in ADHD children and controls (Hedges’ g=0.329, 95% CI=−0.035 to 0.693, p=0.076). (C) There was a significant association between manganese levels and diagnosis of ADHD as shown by pooled adjusted OR (OR=1.849, 95% CI=1.149–2.976, p=0.011).
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; C-type, combined type; DISC-IV, Diagnostic Interview Schedule for Children Version IV; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; I-type, inattention type.
Comparison of previous and current meta-analyses
| Study | Study designs included | Manganese exposure measure | Observed effect |
|---|---|---|---|
| Scassellati et al | Case–control | N/A | N/A |
| Rodríguez-Barranco et al | Case–control, cohort, cross-sectional | Blood, cord blood, hair, placenta, tooth, water | Full-scale IQ, performance IQ, verbal IQ |
| Current study | Case–control, cross-sectional | Blood, hair | ADHD |
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; IQ, intelligence quotient; N/A, not available.
Results of Newcastle–Ottawa Scale scores of recruited studies
| Study | Criteria | Source | Sample method | Newcastle–Ottawa Scale
| Country | ||||
|---|---|---|---|---|---|---|---|---|---|
| Selection | Performance | Detection | Information | Total | |||||
| Shin et al | DSM-IV | Hair | Inductively coupled plasma mass spectrometry | 1 | 5 | 4 | 5 | 15 | Republic of Korea |
| Hong et al | DISC-IV | Blood | Graphite furnace atomic absorption spectrometry | 3 | 5 | 5 | 4 | 17 | Republic of Korea |
| Yousef et al | DSM-IV | Blood | N/A | 2 | 5 | 4 | 4 | 15 | United Arab Emirates |
| Farias et al | DSM-IV | Blood | Graphite furnace atomic absorption spectrometry | 2 | 5 | 4 | 4 | 15 | Brazil |
Abbreviations: DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; DISC-IV, Diagnostic Interview Schedule for Children Version IV; N/A, not available.
Excluded studies and reasons
| Konstantopoulos et al |
| Hu et al |
| Konrad et al |
| Han et al |
| Rodríguez-Barranco et al |
| Scassellati et al |
| Zeng et al |
| Grandjean and Landrigan |
| Lucchini et al |
| Hong et al |
| Bouchard et al |
| Lucchini et al |
| Chan et al |
| Ericson et al |
| Rucklidge et al |
| Bhang et al |
| Liu et al |
| Ode A et al |
Abbreviation: ADHD, attention-deficit/hyperactivity disorder.